SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001619856-23-000130
Filing Date
2023-11-17
Accepted
2023-11-17 16:06:49
Documents
14
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A crbu-20230630.htm   iXBRL 10-Q/A 36116
2 EX-31.1 crbu-20230630xexx311a.htm EX-31.1 10072
3 EX-31.2 crbu-20230630xexx312a.htm EX-31.2 10077
  Complete submission text file 0001619856-23-000130.txt   229798

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20230630.xsd EX-101.SCH 1970
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20230630_lab.xml EX-101.LAB 33135
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20230630_pre.xml EX-101.PRE 17393
8 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20230630_htm.xml XML 3947
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40631 | Film No.: 231418654
SIC: 2836 Biological Products, (No Diagnostic Substances)